Jesús J. Sola-rekin lankidetzan egindako argitalpenak (15)

2016

  1. A single institution’s 21-year experience with surgically resected pancreatic neuroendocrine tumors: An analysis of survival and prognostic factors

    Revista Espanola de Enfermedades Digestivas, Vol. 108, Núm. 11, pp. 689-696

2015

  1. Immune monitoring of immunosuppression withdrawal of liver transplant recipients

    Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116

2014

  1. Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?

    Transplantation Proceedings

2013

  1. Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

    Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944

2010

  1. Intraductal papillary mucinous neoplasms (IPMN) of the pancreas: Clinico-pathologic results

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 5, pp. 314-320

2002

  1. Angiomiolipoma epitelioide hepático

    Cirugia Espanola, Vol. 71, Núm. 2, pp. 92-95

2001

  1. Idiopathic adulthood ductopenia. Long-term follow-up after liver transplantation

    Digestive Diseases and Sciences, Vol. 46, Núm. 7, pp. 1420-1423

1999

  1. Apoptosis and proliferation index in renal biopsies with early chronic rejection and in biopsies from donors older than 60 years

    Transplantation Proceedings

  2. Ischemic injury in posttransplant endomyocardial biopsies: Immunohistochemical study of fibronectin

    Transplantation Proceedings

1998

  1. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation

    Digestive Diseases and Sciences, Vol. 43, Núm. 6, pp. 1186-1189

  2. Preoperative chemotherapy followed by esophaguectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus

    Revista Espanola de Enfermedades Digestivas, Vol. 90, Núm. 4, pp. 283-290

1997

  1. Ischemic damage prevention by N-acetylcysteine treatment of the donor before orthotopic liver transplantation

    Transplantation Proceedings

1994

  1. Percutaneous transhepatic stenting by wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation

    CardioVascular and Interventional Radiology, Vol. 17, Núm. 4, pp. 210-213

1992

  1. Leukotriene C4 detection as an early graft function marker in liver transplantation

    Transplantation Proceedings

  2. Role of leukotrienes B4 and C4 in liver allograft rejection.

    Transplant international : official journal of the European Society for Organ Transplantation, Vol. 5 Suppl 1